Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2024-02-08

Clinical Trial Update: Clinical Study to Assess the Equivalence of Tranexamic Acid vs Oxytocin in Reducing the PPH (TRANOXY2015) [Phase 3]

View source ↗

Summary

Clinical trial comparing tranexamic acid to oxytocin for postpartum hemorrhage was withdrawn (Phase 3).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Oxytocin (Oxytocin)
  • TRANEXAMIC ACID (TRANEXAMIC ACID)

Snippet

Sponsor: Azienda U.S.L. 1 di Massa e Carrara | Conditions: Postpartum Hemorrhage | Phase 3 | Status: WITHDRAWN